11
2023
-
07
Shandong Yumankun Biotechnology Co., Ltd. was awarded the title of Shandong Province Gazelle Enterprise
Classification:
News
Company News
The recognition of Shandong Yumankun as Shandong Gazelle Enterprise has an important impact on the development of the enterprise. First of all, this recognition will bring more reputation and popularity to Shandong Yumankun, and establish a good corporate image in the industry, which will help attract more customers and quality partners. After being recognized as a gazelle enterprise, the company will increase its investment in research and development to improve product quality and technology level to meet market demand and enhance competitiveness. In conclusion, the recognition of Shandong Yumankun as Shandong Gazelle Enterprise will have a positive impact on the development of the enterprise. The company will make full use of this opportunity to plan the development direction, improve product quality and technology level, and practice social responsibility for the health of the general public.
Related News
2023-11-08
On November 6, the ninth batch of national drug centralized volume purchasing meeting was held in Shanghai. Shandong Yumangkun Biotechnology Co., Ltd. consistency evaluation over the evaluation of the product piracetam injection was selected.
2023-09-27
Good News｜Shandong Yumankun Biotechnology Co., Ltd. won the eighth batch of national centralized purchasing of pharmaceutical products.
2023-09-09
Circular of the National Medical Security Bureau on Further Deepening the Intelligent Audit and Monitoring of the Medical Security Fund
2023-08-30
Notice on the Filling of Information on Drugs Related to the Ninth Batch of Centralized Purchasing of Drugs by State Organizations
Address: Room 2602, Huiyuan Building, 38 Huaneng Road, Lixia District, Jinan City, Shandong Province
©Shandong Yumankun Biotechnology Co., Ltd.